Tap to find out if a shot of alcohol can help an irregular heartbeat?
By Sharonya Kundu
Research from the Journal of the American Medical Association (JAMA) confirms the benefit of therapy for persistent atrial fibrillation (AFib) that combines the standard therapy, catheter ablation, with a discrete infusion of alcohol or ethanol to the vein of Marshall.
Miguel Valderrabano, M.D., division chief, cardiac electrophysiology, Houston Methodist, outlined the plan of action, initially using it successfully in 2008. Beginning of the year, he introduced these discoveries at the annual meeting for the American College of Cardiology. Atrial fibrillation mentions an unusual and uneven pulse rate, which can head to stroke, blood clots, and heart failure if left uncured. As a therapy, catheter ablation uses electrical energy to reboot the pulse. While fruitful for some, in many patients, the procedure must be redone various times to reach positive outcomes. The Vein of Marshall Ethanol for Untreated Persistent Atrial Fibrillation (VENUS) was tried on 343 patients, with 155 of them experiencing the amalgamation therapy. At the 6 and 12-month spot, 49 percent of those patients were discharged from atrial fibrillation.
At the same interlude, only 38 percent of patients who experienced catheter ablation solo had the same outcome. AFib is the most often diagnosed arrhythmia. The currency of AFib in the United States ranges from 2.7 million to 6.1 million, as claimed by the Centers for Disease Control and Prevention. Discoveries from the multicenter case prove that the amalgamation proposal is a functional first-line therapy and could be included as the standard of care. For patients, it expands their possibility of only one procedure to return to good health, removing the stress and anxiety that can conduct frequent surgical procedures.